H-Index
73
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo



eISSN: 1643-3750


Published: 2019-03-24

Downregulation of miR-222-3p Reverses Doxorubicin-Resistance in LoVo Cells Through Upregulating Forkhead Box Protein P2 (FOXP2) Protein

Huaiming Wang, Zhenwei Deng, Xinhua Chen, Jian Cai, Tenghui Ma, Qinghua Zhong, Ruiping Li, Libo Li, Tian Li

(Department of Colorectal Surgery, Laboratory of Colorectal and Pelvic Floor Disease, The Sixth Affilliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (mainland))

Med Sci Monit 2019; 25:2169-2178

DOI: 10.12659/MSM.913325


BACKGROUND: Doxorubicin (DOX) is a potent chemotherapeutic agent used to treat colon cancer. Despite impressive initial clinical responses, drug resistance has dramatically compromised the effectiveness of DOX. However, the underlying mechanisms of chemotherapeutic resistance in colon cancer remain poorly understood.
MATERIAL AND METHODS: In this study, we compared the expression of miR-222-3p in DOX-resistant colon cancer cells (LoVo/ADR) with the corresponding DOX-sensitive parental cells (LoVo/S) using quantitative real-time PCR. In addition, miR-222-3p inhibitors were infected into LoVo/ADR cell lines and the effects of this treatment were assessed. The Cell Counting Kit 8 assay was employed to verify the sensitivity of colon cancer cell lines to DOX. EdU (5-ethynyl-2’-deoxyuridine) assay, flow cytometry, and in vivo subcutaneous tumorigenesis were used to assess cell proliferation and apoptosis. Transwell and wound healing assays were used to investigate cell migration after adding DOX. Additionally, the expression of forkhead box protein P2 (FOXP2), P-glycoprotein (P-gp) and caspase pathway-associated markers was assessed by western blotting.
RESULTS: Our results showed that miR-222-3p was upregulated in LoVo/ADR compared with the expression in LoVo/S cells. Additionally, downregulation of miR-222-3p in LoVo/ADR cells increased their sensitivity to DOX, reduced P-gp expression, and activated the caspase pathway. However, the downregulation of FOXP2 could efficiently reverse the effect of miR-222-3p inhibitors on LoVo/ADR cells.
CONCLUSIONS: Taken together, our results showed that miR-222-3p induced DOX resistance via suppressing FOXP2, upregulating P-gp, and inhibiting the caspase pathway.

Keywords: Caspases, Colonic Neoplasms, Drug Resistance, MicroRNAs, P-Glycoprotein



Related Articles (0)

Coming Soon...

Published: 2019-03-23

MicroRNA-744 Inhibits Proliferation of Bronchial Epithelial Cells by Regulating Smad3 Pathway via Targeti...


Han Huang, Hongxia Lu, Lihong Liang, Yueli Zhi, Beibei Huo, Linlin Wu, Liping Xu, Zhaobo Shen

Med Sci Monit 2019; 25:2159-2168

DOI: 10.12659/MSM.912412

Published: 2019-03-23

Immunoporosis: A New Role for Invariant Natural Killer T (NKT) Cells Through Overexpression of Nuclear Fa...


Konstantinos Tilkeridis, Georgios Kiziridis, Athanasios Ververidis, Menelaos Papoutselis, Ioannis Kotsianidis, Gesthimani Kitsikidou, Natalia-Efthalia Tousiaki, Georgios Drosos, Artemis Kapetanou, Katerina Vlastimil Rechova, Konstantinos Kazakos, Emmanouil Spanoudakis

Med Sci Monit 2019; 25:2151-2158

DOI: 10.12659/MSM.912119